PyInvesting

Market research

HYL.BR Hyloris Pharmaceuticals SA

BR EUR Healthcare

Latest close

4.30 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
112M
P/E ratio
Not available
Analyst target
11.2333
Dividend yield
Not available
Beta
0.65

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Hyloris Pharmaceuticals SA is currently in a long term uptrend where the price is trading 15.3% above its 200 day moving average.

From a valuation standpoint, the stock is 96.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2541.1.

Based on the above factors, Hyloris Pharmaceuticals SA gets an overall score of 2/5.